New commercials in the streaming era aim to infiltrate TV terrain that has been off-limits to advertisers for years ...

The company announced on 18 February that the trial did not meet its primary endpoint measured by a depression rating scale, ...

A grandad takes his granddaughter for a perfectly pleasant day at the park in Zak Razvi’s endearing spot for the UK bus ...

While publitec will start to sell all the Barco products, that specifically fit the event sector, its partner company, NicLen ...

Generative AI has radically transformed digital creation. AI image generators can produce pictures from just a few words in a prompt, and it's becoming easier than ever to find and use these programs.

Eldredge finally found relief. He said things immediately got better about six months ago when he tried Spravato. “It’s so life-changing,” said Eldredge. Spravato is a ketamine-derived nasal ...

We torture-test a dozen of the most popular text-to-image AI tools with a series of prompts designed to highlight their strengths and weaknesses. Here's how they stack up. I've been writing about ...

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the immediate impact Spravato has had on patients with treatment-resistant ...

An estimated 21 million American adults suffer from clinical depression. © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

The UK healthcare cost-effectiveness agency has said it will not recommend funding for Johnson & Johnson’s antidepressant nasal spray Spravato on the NHS, because of cost and clinical concerns.

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the approval of Spravato for treatment-resistant depression. PE: How does ...